Five drug companies accused of ripping off the National Health Service by overcharging for generic medicines look set to escape criminal prosecution after a judge threw out the charges against them.

Yesterday's collapse of the £25m investigation is an-other blow for the Serious Fraud Office, which has been pursuing the case for more than eight years.